Benzatropine
Back to search| Scientific Name: | Benzatropine |
| Brand Name: | Cogentin |
| Company Owner: | Hikma farmaceutica (portugal) sa, Nexus pharmaceuticals inc, Pharmaforce inc, Lundbeck inc, Actavis totowa llc, Corepharma llc, Invagen pharmaceuticals inc, Lannett holdings inc, Mutual pharmaceutical co inc, Pliva inc, Quantum pharmics ltd, Usl pharma inc, Vintage pharmaceuticals llc, Merck and co inc |
| Mechanism Of Action | Benztropine is an agent with anti-muscarinic and antihistaminic effects. Its main mechanism of action is presented by the selective inhibition of dopamine transporters but it also presents affinity for histamine and muscarine receptors. |
| Description of the Drug: | Benzatropine is an anticholinergic drug used to treat Parkinson’s disease (PD) and extrapyramidal symptoms, except tardive dyskinesia. |
| Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00245
